Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription 08.07.2024 1 AJR Am J Roentgenol 2 Ann Oncol 3 Arch Bronconeumol 3 BMC Cancer 1 Br J Cancer 1 Cancer 1 Cancer Epidemiol Biomarkers Prev 1 Chest 1 Clin Cancer Res 1 Clin Exp Metastasis 5 Clin Lung Cancer 1 Clin Nucl Med 2 Eur Respir J 1 Int J Cancer 1 J Clin Oncol 2 JAMA Oncol 3 Lung Cancer 2 Oncologist 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. MANAPRAGADA PP
   Editorial Comment: Ground-Glass Opacity Component in Early-Stage Lung Cancer-Even a Little Is Quite Good!
   AJR Am J Roentgenol. 2024 Jul 3. doi: 10.2214/AJR.24.31586.
   PubMed        
   
   

   
   Ann Oncol

2. FELIP E, Cho BC, Gutierrez V, Alip A, et al
   Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA.
   Ann Oncol. 2024 Jun 26:S0923-7534(24)00702-6. doi: 10.1016/j.annonc.2024.
   PubMed         Abstract available
   
   
3. DI FEDERICO A, Alden SL, Smithy JW, Ricciuti B, et al
   Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small cell lung cancer.
   Ann Oncol. 2024 Jun 29:S0923-7534(24)00745-2. doi: 10.1016/j.annonc.2024.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

4. CASCON-HERNANDEZ J, Lopez-Garcia J, Saidi I
   Right Adrenal Metastasis of Lung Cancer Diagnosed via Endoscopic Ultrasound (EUS-B) by a Pulmonologist.
   Arch Bronconeumol. 2024 Jun 18:S0300-2896(24)00230.
   PubMed        
   
   
5. OZTURK ERGUR F, Ozturk A, Ozdag O, Tatci E, et al
   When to Consider Invasive Lymph Node Staging in Non-Small-Cell Lung Cancer? A Novel Scoring System Utilising Metabolic Parameters in 18F-FDG PET/CT.
   Arch Bronconeumol. 2024 May 28:S0300-2896(24)00184.
   PubMed         Abstract available
   
   
6. HUANG S, Li F
   Progressive Metastatic Pulmonary Calcification: CT, MR and Bone Scintigraphy.
   Arch Bronconeumol. 2024;60:437-438.
   PubMed        
   
   

   
   BMC Cancer

7. CHENG Y, Zhang C, Li Q, Yang X, et al
   MTF1 genetic variants are associated with lung cancer risk in the Chinese Han population.
   BMC Cancer. 2024;24:778.
   PubMed         Abstract available
   
   
8. YAN L, Su H, Liu J, Wen X, et al
   Rapid detection of lung cancer based on serum Raman spectroscopy and a support vector machine: a case-control study.
   BMC Cancer. 2024;24:791.
   PubMed         Abstract available
   
   
9. LIN P, Zhang L, Tang X, Wang J, et al
   Exploring the causal association between uric acid and lung cancer in east Asian and European populations: a mendelian randomization study.
   BMC Cancer. 2024;24:801.
   PubMed         Abstract available
   
   

   
   Br J Cancer

10. ZHAO Y, Zheng Y, Fu J, Zhang J, et al
    KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer.
    Br J Cancer. 2024 Jun 29. doi: 10.1038/s41416-024-02772.
    PubMed         Abstract available
    
    

    
    Cancer

11. CHO H, Kwon H, Kim SH, Ahn HM, et al
    Seasonal influences on the efficacy of anti-programmed cell death (ligand) 1 inhibitors in lung cancer.
    Cancer. 2024 Jun 28. doi: 10.1002/cncr.35454.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

12. TRENDOWSKI MR, Watza D, Lusk CM, Lonardo F, et al
    Evaluation of the Immune Response within the Tumor Microenvironment in African American and non-Hispanic White Non-Small Cell Lung Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2024 Jul 2. doi: 10.1158/1055-9965.EPI-24-0333
    PubMed         Abstract available
    
    

    
    Chest

13. HWANG AR, Mesfin N, Kogut M, Foster MV, et al
    Percutaneous Lung Biopsy Prevalence and use of Lung-RADS in the Veterans Health Administration Lung Cancer Screening Program.
    Chest. 2024 Jun 28:S0012-3692(24)00811-0. doi: 10.1016/j.chest.2024.
    PubMed        
    
    

    
    Clin Cancer Res

14. YANG SR, Jayakumaran G, Benhamida J, Febres-Aldana CA, et al
    Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features.
    Clin Cancer Res. 2024;30:2780-2789.
    PubMed         Abstract available
    
    

    
    Clin Exp Metastasis

15. HORIMOTO Y, Hlaing MT, Saeki H, Denda-Nagai K, et al
    Glycosylation profiles of breast cancer cells may represent clonal variations of multiple organ metastases.
    Clin Exp Metastasis. 2024 Jan 9. doi: 10.1007/s10585-023-10253.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

16. ZHANG Y, Chen Z, Chen G, Huang Y, et al
    The Design for a Phase II, Randomized, Multicenter Study of CtDNA-Guided Treatment With Furmonertinib Combined Therapy or Furmonertinib Alone for Untreated Advanced EGFR Mutant Non-small-cell Lung Cancer Patients: The FOCUS-C Study.
    Clin Lung Cancer. 2024 Jun 10:S1525-7304(24)00111.
    PubMed         Abstract available
    
    
17. MUSCOLINO P, Scimone C, Sapuppo E, Micali V, et al
    Gefitinib Resensitization After a TKI-Free Interval in Osimertinib Resistant Non-Small-Cell Lung Cancer: A Glimpse of Hope in Time of Crisis?
    Clin Lung Cancer. 2024 Jun 10:S1525-7304(24)00112.
    PubMed        
    
    
18. SHARMA P, Mahadevia H, Donepudi S, Kujtan L, et al
    A Novel EGFR Germline Mutation in Lung Adenocarcinoma: Case Report and Literature Review.
    Clin Lung Cancer. 2024;25:479-482.
    PubMed        
    
    
19. KUDO Y, Nakamura T, Matsubayashi J, Ichinose A, et al
    AI-driven Characterization of Solid Pulmonary Nodules on CT Imaging for Enhanced Malignancy Prediction in Small-sized Lung Adenocarcinoma.
    Clin Lung Cancer. 2024;25:431-439.
    PubMed         Abstract available
    
    
20. PETRINI I, Bruno R, Di Stefano I, Aprile V, et al
    A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR Mutations.
    Clin Lung Cancer. 2024;25:e238-e242.
    PubMed        
    
    

    
    Clin Nucl Med

21. KWON SJ, Yoo IR, Jung JI
    Post-RFA Pulmonary Vein Stenosis Mimicking Lymphangitic Carcinomatosis in a Patient With History of Liposarcoma.
    Clin Nucl Med. 2024;49:e412-e414.
    PubMed         Abstract available
    
    

    
    Eur Respir J

22. RASKIN J, Surmont V, Maat APWM, Yahia M, et al
    A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205.
    Eur Respir J. 2024;63:2302114.
    PubMed         Abstract available
    
    
23. PORCEL JM
    Pleural mesothelioma: surgery questioned again?
    Eur Respir J. 2024;63:2400896.
    PubMed        
    
    

    
    Int J Cancer

24. ZHANG Q, Chen K, Yu X, Fan Y, et al
    Spotlight on the treatment of non-small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives.
    Int J Cancer. 2024 Jul 3. doi: 10.1002/ijc.35070.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

25. WALIANY S, Lin JJ
    Taletrectinib: TRUST in the Continued Evolution of Treatments for ROS1 Fusion-Positive Lung Cancer.
    J Clin Oncol. 2024 Jun 28:JCO2401062. doi: 10.1200/JCO.24.01062.
    PubMed        
    
    

    
    JAMA Oncol

26. TAKEMURA N, Lin CC
    More Benefits of Tai Chi Than Aerobic Exercise in Patients With Advanced Lung Cancer-Reply.
    JAMA Oncol. 2024 Jul 3. doi: 10.1001/jamaoncol.2024.2456.
    PubMed        
    
    
27. TSAI CH, Chiang PH
    More Benefits of Tai Chi Than Aerobic Exercise in Patients With Advanced Lung Cancer.
    JAMA Oncol. 2024 Jul 3. doi: 10.1001/jamaoncol.2024.2453.
    PubMed        
    
    

    
    Lung Cancer

28. BUM LEE J, Huang Y, Oya Y, Nutzinger J, et al
    Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunities.
    Lung Cancer. 2024;194:107862.
    PubMed         Abstract available
    
    
29. METINTAS M, Ak G, Metintas S
    Environmental asbestos exposure and lung cancer.
    Lung Cancer. 2024;194:107850.
    PubMed         Abstract available
    
    
30. BEN-ARYE E, Gressel O, Lifshitz S, Peled N, et al
    Integrative oncology for patients with lung cancer: A prospective pragmatic controlled trial.
    Lung Cancer. 2024;193:107857.
    PubMed         Abstract available
    
    

    
    Oncologist

31. CHENG W, Xu T, Yang L, Yan N, et al
    Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer.
    Oncologist. 2024 Jul 2:oyae166. doi: 10.1093.
    PubMed         Abstract available
    
    
32. CHANG AEB, Piper-Vallillo AJ, Mak RH, Lanuti M, et al
    The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.
    Oncologist. 2024;29:609-618.
    PubMed         Abstract available
    
    

    
    PLoS One

33. 
    Correction: Efficient gene transfection to lung cancer cells via Folate-PEI-Sorbitol gene transporter.
    PLoS One. 2024;19:e0306665.
    PubMed         Abstract available
    
    
34. USHER-SMITH JA, Masson G, Godoy A, Burge SW, et al
    Acceptability of adding a non-contrast abdominal CT scan to screen for kidney cancer and other abdominal pathology within a community-based CT screening programme for lung cancer: A qualitative study.
    PLoS One. 2024;19:e0300313.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

35. LARA-SAEZ I, Mencia A, Recuero E, Li Y, et al
    Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models.
    Proc Natl Acad Sci U S A. 2024;121:e2322917121.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.